We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Avacta Group Plc Announces SARS-CoV-2 Rapid Antigen Test Update

Product News   Nov 23, 2020

 
Avacta Group Plc Announces SARS-CoV-2 Rapid Antigen Test Update

Alastair Smith, Chief Executive Officer of Avacta Group. Credit: Avacta Group

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases

Product News

The breath biomarker panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF.

READ MORE

Rapid, Cost-Efficient Sample Processing in Workflows

Product News

Novel RHINOstic™ swab collection device and LabElite® DeCapper increase sample throughput and consistency compared to manual methods.

READ MORE

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Product News

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE